- ·Watch 35Pharma: the Monday email on marks, rounds and moves
35Pharma funding history
No funding rounds for 35Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
35Pharma valuation
35Pharma's last known valuation is $950 million, from Apr 2026. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How 35Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For 35Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about 35Pharma
- What is 35Pharma worth?
- 35Pharma's last known valuation is $950.0M.
- How much has 35Pharma raised?
- 35Pharma has raised $70.0M in total funding across its recorded rounds.